eFFECTOR Therapeutics's market cap is currently $941.00. The company's EPS TTM is $-13.315; its P/E ratio is ―; eFFECTOR Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 3.55M	$ 1.43M	$ 42.00M	$ 0.00
Gross Profit	$ -22.92M	$ 3.50M	$ 1.41M	$ 20.17M	$ -307.00K
Operating Income	$ -33.84M	$ -32.40M	$ -31.90M	$ 15.82M	$ -28.61M
EBITDA	$ -33.73M	$ -32.40M	$ -31.90M	$ 16.05M	$ -28.30M
Net Income	$ -35.81M	$ -12.93M	$ 15.80M	$ 14.21M	$ -29.74M
Balance Sheet
Cash & Short-Term Investments	$ 18.37M	$ 26.31M	$ 49.70M	$ 15.22M	$ 3.43M
Total Assets	$ 20.54M	$ 29.08M	$ 54.06M	$ 16.70M	$ 5.09M
Total Debt	$ 20.55M	$ 20.28M	$ 20.03M	$ 12.96M	$ 15.24M
Net Debt	$ 5.67M	$ 11.57M	$ -29.67M	$ -2.25M	$ 11.82M
Total Liabilities	$ 26.34M	$ 25.18M	$ 36.77M	$ 148.95M	$ 18.93M
Stockholders' Equity	$ -5.79M	$ 3.90M	$ 17.28M	$ -132.25M	$ -13.84M
Cash Flow
Free Cash Flow	$ -29.65M	$ -26.09M	$ -24.93M	$ 13.68M	$ -27.60M
Operating Cash Flow	$ -29.55M	$ -25.90M	$ -24.89M	$ 13.84M	$ -27.60M
Investing Cash Flow	$ 14.48M	$ -17.86M	$ 565.00K	$ -154.00K	$ 84.00K
Financing Cash Flow	$ 21.23M	$ 2.77M	$ 58.81M	$ -1.89M	$ 20.24M

Currency in USD

eFFECTOR Therapeutics Earnings and Revenue History

Income Statement >

eFFECTOR Therapeutics Debt to Assets

Balance Sheet >

eFFECTOR Therapeutics Cash Flow

Cash Flow >

eFFECTOR Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing